CD4 c.187G>A ;(p.G63R)

Variant ID: 12-6909610-G-A

NM_000616.4(CD4):c.187G>A;(p.G63R)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


A nanoparticle vaccine that targets neoantigen peptides to lymphoid tissues elicits robust antitumor T cell responses.

Npj Vaccines
Arbelaez, Carlos A CA; Estrada, Juan J; Gessner, Melissa A MA; Glaus, Charles C; Morales, Agnieszka B AB; Mohn, Deanna D; Phee, Hyewon H; Lipford, J Russell JR; Johnston, James A JA
Publication Date: 2020-11-12

Variant appearance in text: CD4: G63R
PubMed Link: 33298945
Variant Present in the following documents:
  • Main text
  • 41541_2020_Article_253.pdf
View BVdb publication page



Mutant MHC class II epitopes drive therapeutic immune responses to cancer.

Nature
Kreiter, Sebastian S; Vormehr, Mathias M; van de Roemer, Niels N; Diken, Mustafa M; Löwer, Martin M; Diekmann, Jan J; Boegel, Sebastian S; Schrörs, Barbara B; Vascotto, Fulvia F; Castle, John C JC; Tadmor, Arbel D AD; Schoenberger, Stephen P SP; Huber, Christoph C; Türeci, Özlem Ö; Sahin, Ugur U
Publication Date: 2015-04-30

Variant appearance in text: CD4: G63R
PubMed Link: 25901682
Variant Present in the following documents:
  • Main text
View BVdb publication page